Suppression of the malignant phenotype of human prostate cancer cell line PPC-1 by introduction of normal fragments of human chromosome 10

Cancer Research

Volumn 56, Issue 9, 1996, Pages 2157-2160

  Murakami, Yoshinori S ^a,c   Albertsen, Hans ^a   Brothman, Arthur R ^a   Leach, Robin J ^b   White, Raymond L ^a,d  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^d UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANTIBIOTIC RESISTANCE; ARTICLE; CANCER CELL CULTURE; CHROMOSOME 10; GENE LOCATION; GENE TRANSFER; GENETIC ANALYSIS; GENETIC HETEROGENEITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; STRUCTURE ANALYSIS; TUMOR SUPPRESSOR GENE;

ANIMALS; CHROMOSOMES, HUMAN, PAIR 10; DRUG RESISTANCE, NEOPLASM; GENE TRANSFER TECHNIQUES; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MICE; NEOMYCIN; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0029875164     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Coffey, D. S., Benson, M. C., Chiarodo, A., Gardner, W. A , Hanks, G. E., Hayes, R. B., Isaacs, W. B., Karr, J. P., Kolonel, L. N , Lange, P. H., Miller, G J., Olsson, C. A , Rifkin, M D., Ross, R. K., Scardino, P T., Schellhammer, P F., Story, M T., and Tindall, D. J. National Cancer Institute roundtable on prostate cancer: future research directions Cancer Res , 51: 2498-2505, 1991
2. Boring, C. C , Squires, T. S., Tong, T., and Montgomery, S. Cancer Statistics. CA Cancer J. Clin., 44: 7-26, 1994.
3. Garnick, M. B. The dilemmas of prostate cancer. Sci. Am., 270: 72-81, 1994.
4. Carter, B. S., Weing, C. M., Ward, W. S., Treiger, B. F., Alders, T. W. Schalken, J A., Epstein, J. I., and Isaacs, W. B Allelic loss of chromosome 16q and 10q in human prostate cancer. Proc. Natl. Acad. Sci. USA, 87: 8751-8755, 1990.
5. Bergerheim, U S. R., Kunimi, K., Collins, V. P., and Ekman, P. Deletion mapping of chromosome 8, 10, and 16 in human prostatic carcinoma. Genes Chromosomes & Cancer, 3. 215-220, 1991
6. Kunimi, K., Bergerheim, U. S. R., Larsson, I L., Ekman, P., and Collins, V. P. Allelotyping of human prostatic adenocarcinoma. Genomies, 11: 530-535, 1991.
7. Bova, G. S , Carter, B. S., Bussemakers, M. J. G., Emi, M., Fujiwara, Y., Natasha, K., Jacobs, S C., Robinson, J. C., Epstein, J. I., Walsh, P. C., and Isaacs, W. B. Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer Cancer Res., 53: 3869-3873, 1993
8. MacGrogan, D , Levy, A., Bostwick, D , Wagner, M., Wells, D., and Bookstein, R. Loss of chromosome 8p loci in prostate cancer, mapping by quantitative allelic imbalance. Genes Chromosomes & Cancer, 10: 151-159, 1994.
9. Brothman, A. R., Steele, M R., Williams, B. J., Jones, E., Odelberg, S., Albertsen, H. M., Jorde, L. B., Rohr, L. R., and Stephenson, R. A. Loss of chromosome 17 loci in prostate cancer detected by polymerase chain reaction quantitation of allelic markers. Genes Chromosomes & Cancer, 13: 278-284, 1995.
10. Brothman, A. R., Peehl, D M., Patel, A. M., and McNeal, J. E. Frequency and pattern of karyotypic abnormalities in human prostate cancer. Cancer Res., 50: 3795-3803, 1990.
11. Eagle, L. R., Yin, X., Brothman, A. R., Williams, B. J., Alkin, N. B , and Prochownik, E. V Mutation of the Mxil gene in prostate cancer. Nat. Genet., 9: 249-255, 1995.
12. Tanaka, K., Oshimura, M., Kikuchi, R., Seki, M., Hayashi, T , and Miyaki, M Suppression of tumorigenicity in human colon carcinoma cells by introduction of normal chromosome 5 or 18. Nature (Lond.), 349. 340-342, 1991.
13. Ichikawa, T., Ichikawa, Y., and Isaacs, J. T. Genetic factors and suppression of metastatic ability of prostate cancer. Cancer Res., 51: 3788-3792, 1991
14. Banerjee, A., Xu, H-J., Hu, S-X., Araujo, D , Takahashi, R., Stanbridge, E J., and Benedict, W. F. Changes in growth and tumorigenicity following reconstitution of retinoblastoma gene function in various cancer cell types by microcell transfer of chromosome 13. Cancer Res., 52: 6297-6304, 1992.
15. Casey, G., Plummer, S., Hoeltge, G., Scanlon, D., Fasching, C , and Stanbridge, E. J Functional evidence for a breast cancer growth suppressor gene on chromosome 17 Hum. Mol. Genet , 2: 1921-1927, 1993.
16. Koi, M , Johnson, L A , Kalikin, L. M., Little, P. F. R., Nakamura, Y., and Feinberg, A. P. Tumor cell growth arrest caused by subchromosomal transferable DNA fragments from chromosome 11. Science (Washington DC), 260. 361-364, 1993.
17. Goyette, M. C., Cho, K., Fasching, C. L., Levy, D. B., Kinzler, K. W , Paraskeva, C., Vogelstein, B., and Stanbridge, E. J. Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer. Mol. Cell Biol., 12: 1387-1395, 1992.
18. Murakami, Y. S., Brothman, A. R., Leach, R. J., and White, R. L. Suppression of malignant phenotype in a human prostate cancer cell line by fragments of normal chromosome region 17q Cancer Res., 55: 3389-3394, 1995.
19. Dong, J-T., Lamb, P. W., Rinker-Schaeffer, C W , Vukanovic, J., Ichikawa, T , Isaacs, J T., and Barrett, C. Kail, a metastasis suppressor gene for prostate cancer on human chromosome I 1p11.2. Science (Washington DC), 268: 884-886, 1995.
20. Pershouse, M A , Stubblefield, E., Hadi, A., Killary, A. M., Yung, W. K. A , and Steck, P. A. Analysis of the functional role of chromosome 10 loss in human glioblastomas. Cancer Res., 53: 5043-5050, 1993
21. Brothman, A. R , Lesho, L. J., Sommers, K. D., Wright, G. L., Jr., and Merchant, D J Phenorypic and cytogenetic characterization of a cell line derived from primary prostate carcinoma. Int. J Cancer, 44: 898-903, 1989.
22. Fournier, R. E. K. A general high-efficiency procedure for production of microcell hybrids. Proc. Natl Acad Sci. USA, 78: 6349-6353, 1981.
23. Blin, N , and Stafford, D. M. A general method for isolation of high-molecular-weight DNA from eukaryotes. Nucleic Acids Res., 3: 2303-2308, 1976.
24. Albertsen, H., Plaetke, R., Ballard, L., Fujimoto, E., Connolly, J., Lawrence, E , Rodnguez, P., Robertson, M., Bradley, P., Miliner, B., Fuhrman, D., Marks, A , Sargent, R., Cartwright, P. Matsunami, N., and White, R. Genetic mapping of the BRCA1 region on chromosome 17q21, Am. J Hum. Genet., 54 516-525, 1994.
25. Brothman, A. R., Wilkins, P. C., Sales, E. W., and Sommers, K. D. Metastaric properties of the human prostatic cell line, PPC-1, in athymic nude mice. J. Urol., 145: 1088-1091, 1991.
26. Brothman, A R., and Patel, A. M. Characterization of 10 marker chromosomes in a prostatic cancer cell line by in situ hybridization. Cytogenet. Cell Genet., 60: 8-11, 1992.
27. Utah Marker Development Group A collection of ordered tetranucleotide repeat markers from the human genome Am. J. Hum. Genet., 57: 619-628, 1995.
28. Steck, P. A , Ligon, A. H., Cheong, P., Yung, W. K. A., and Pershouse, M. A. Two tumor suppressive loci on chromosome 10 involved in human glioblastomas. Genes Chromosomes & Cancer, 12: 255-261, 1995.
29. Fujimoto, M., Fults, D W., Thomas, G. A., Nakamura, Y., Heilbrun, M. P., and Sheridan, P. J. Loss of heterozygosity on chromosome 10 in human glioblastoma multiforme. Genomics, 4: 210-214, 1989
30. Fults, D., Pedone, A. C., Thomas. G. A., and White, R. Allelotype of human malignant astrocytoma. Cancer Res., 50. 5784-5789, 1990.
31. Carter, B S. Hereditary prostate cancer epidemiologic and clinical features J Urol. 150: 797-802, 1993